产品名称
Anti-phospho-GSK-3α Ser21 Antibody, clone 1E22 ZooMAb® Rabbit Monoclonal, recombinant, expressed in HEK 293 cells
isotype
IgG
biological source
rabbit
recombinant
expressed in HEK 293 cells
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
1E22, recombinant monoclonal
recombinant monoclonal
description
1E22 Clone
product line
ZooMAb® learn more
form
lyophilized
mol wt
calculated mol wt 50.98 kDa
observed mol wt ~50 kDa
purified by
using Protein A
species reactivity
mouse, human
species reactivity (predicted by homology)
feline, canine, monkey, bovine, rat, horse
packaging
antibody small pack of 25 μL
greener alternative product characteristics
Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.
enhanced validation
recombinant expression
Learn more about Antibody Enhanced Validation
sustainability
Greener Alternative Product
technique(s)
flow cytometry: suitable
immunocytochemistry: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
peptide synthesis: suitable
western blot: suitable
epitope sequence
N-terminal
Protein ID accession no.
UniProt accession no.
greener alternative category
shipped in
ambient
storage temp.
2-8°C
target post-translational modification
phosphorylation (pSer21)
Quality Level
Gene Information
human ... GSK3A(2931)
Application
Evaluated by Western Blotting in lysate from HEK293 cells treated with EGF.
Western Blotting Analysis: A 1:10,000 dilution of this antibody detected GSK-3a phosphorylated on serine 21 in lysate of HEK293 cells overnight starved and treated with epidermal growth factor (50 ng/mL; 10 min.).
Tested applications
Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected phospho-GSK-3a-Ser21 in lysate from NIH3T3 cells treated with PDGF.
Peptide Inhibition Assay:: Target band detection in a lysate from HEK293 cells treated with epidermal growth factor (50 ng/mL; 10 min) was prevented by preblocking of a representative lot with the immunogen phosphopeptide, but not the corresponding non-phosphopeptide.
Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected phospho-GSK-3a-Ser21 in human breast cancer tissue sections.
Immunocytochemistry Analysis: A 1:1,000 dilution from a representative lot detected phospho-GSK-3a-Ser21 in Hek293 treated with EGF cell line.
Flow Cytometry Analysis: 0.1 μg from a representative lot detected phospho-GSK-3a-Ser21 in HEK293 cells treated with EGF.
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Biochem/physiol Actions
Disclaimer
General description
Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.
Immunogen
Physical form
Preparation Note
Legal Information
未找到合适的产品?
试试我们的产品选型工具.
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持